A detailed history of New Millennium Group LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, New Millennium Group LLC holds 99 shares of CORT stock, worth $5,088. This represents 0.0% of its overall portfolio holdings.

Number of Shares
99
Previous 116 14.66%
Holding current value
$5,088
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$29.51 - $46.26 $501 - $786
-17 Reduced 14.66%
99 $4,000
Q2 2024

Jul 25, 2024

BUY
$22.21 - $34.48 $2,576 - $3,999
116 New
116 $3,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.51B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track New Millennium Group LLC Portfolio

Follow New Millennium Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Millennium Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Millennium Group LLC with notifications on news.